Research and Clinical Trials

Research revealed DNA sequences associated with response to abiraterone acetate to identify additional treatments for men with advanced prostate cancer resistant to standard therapies.

Mayo Clinic researchers are working to develop personalized therapeutic cancer vaccines that could potentially target each person's distinctive tumor characteristics.

Researchers developed an algorithm to improve the prediction of colorectal cancer recurrence.

Dr. Andrew Feldman and his team are helping to redefine the classification of T-cell lymphomas, an often fatal group of immune system tumors.

Dr. Reona Sakemura is researching treatment resistance mechanisms in multiple myeloma to make immunotherapy more effective.

Researchers found the drug erlotinib reduced the number of polyps formed in the bowels of patients with Familial Adenomatous Polyposis (FAP).

Komal Singh, Ph.D., is researching the link between nausea and the bacteria, viruses and fungi that inhabit the gastrointestinal tract.

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.

Study finds radiomics-based machine learning models may detect pancreatic cancer on CT scans earlier than current methods for diagnosis.

The story of how Dawn Botsford conquered melanoma with the support of her family, her Mayo Clinic care team and a clinical trial.